ECRITEN
100MG TBL FLM 4
SÚKL code | 0202883 |
---|---|
Name of the product | ECRITEN 100 MG POTAHOVANÉ TABLETY |
_MA_MEDICATION_DETAIL_INFO_MED_NAME i | ECRITEN |
Supplement | 100MG TBL FLM 4 |
Strenght | 100MG |
Pharmaceutical form | Film-coated tablet |
Package | 4 |
Route | Oral use |
Language of the pack | Czech |
Wrap type | Blister |
Legal status | na lékařský předpis |
Active substance | SILDENAFIL CITRATE (SILDENAFILI CITRAS) |
ATC group | G04BE03 |
ATC group name | SILDENAFIL |
Marketing authorisation information
Registration Number | 83/ 654/10-C |
---|---|
Type of MA | A mutual recognition procedure (MRP, DCP), where CZ is Reference member state |
MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
Placed on the market till | 31. 07. 2020 |
MA Holder | PharmaSwiss Česká republika s.r.o., Praha |
MA Holder country | ČESKÁ REPUBLIKA |
Actual MA holder | Bausch Health Ireland Limited, Dublin |
Actual MA holder country | IRSKO |